Company / Interest Expense per Share
CHINA PHARMA HOLDINGS, INC. Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.01
FY2025
5-year range
$0.00 / $0.09
FY2021-FY2025
Trend
+190.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share returned to growth in FY2025 after 2 years of decline, reaching $0.01.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +2.5%.
Improved from $0.02 to $0.01 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -55.0%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share increased 190.6% year-over-year.
- Peak interest expense per share was recorded in FY2022.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +190.6% |
| FY2024 | $0.00 | -85.9% |
| FY2023 | $0.02 | -77.8% |
| FY2022 | $0.09 | +1322.6% |
| FY2021 | $0.01 | -12.6% |
| FY2020 | $0.01 | -28.7% |
| FY2019 | $0.01 | -16.3% |
| FY2018 | $0.01 | -36.5% |
| FY2017 | $0.02 | +172.9% |
| FY2016 | -$0.03 | -248.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026